Pionyr Immunotherapeutics

0 followers

Pionyr Immunotherapeutics discovers and develops first-in-class biologic drugs that fine-tune natural immune responses to increase immune defenses for diseases such as cancer, or to dampen immune responses in autoimmune diseases.


Org chart

Steven P. James
President & CEO
Collapse
Marc Chamberlain
Senior Medical Director
Isabel Luther
Senior Director, Clinical Operations
Davide Edghill
Senior Director, Data Management
Linda Liang
VP, Protein Sciences
Tony Brew
Senior Director & Head of IT

Board & advisors

Rishi Gupta
Director
Mike Ross
Director
J.c. Lopez
Director